The Montreal model clinical team proposes a trial of benzodiazepine and related sedative (BZDR) discontinuation for all patients, which typically entails a slow taper such that final doses occur within several days of the first ketamine treatment, due to evidence that benzodiazepines may dampen or shorten the antidepressant effects of ketamine.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (3)

• ketamine concept
• Montreal model concept
• benzodiazepines concept